Free Access
Med Sci (Paris)
Volume 29, Number 6-7, Juin–Juillet 2013
Page(s) 579 - 582
Section Nouvelles
Published online 12 July 2013
  1. Germain DP. Fabry disease. Orphanet J Rare Dis 2010 ; 5 : 30. [CrossRef] [PubMed] [Google Scholar]
  2. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry’s disease. N Eng J Med 2001 ; 345 : 9–16. [CrossRef] [Google Scholar]
  3. Schiffmann R, Kopp JB, Austin HA, 3rd, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001 ; 285 : 2743–2749. [CrossRef] [PubMed] [Google Scholar]
  4. Mendre C, Mouillac B. Chaperons pharmacologiques. Med Sci (Paris) 2010 ; 26 : 627–635. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Fan JQ, Ishii S, Asano N, Suzuki Y. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 1999 ; 5 : 112–115. [CrossRef] [PubMed] [Google Scholar]
  6. Germain DP, Fan JQ. Pharmacological chaperone therapy by active-site-specific chaperones in Fabry disease: in vitro and preclinical studies. Int J Clin Pharmacol and Ther 2009 ; 47 : S111–S117. [Google Scholar]
  7. Germain DP, Giugliani R, Hughes DA, et al. Safety, pharmacodynamic effects of a pharmacological chaperone on alpha-galactosidase A activity, globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies. Orphanet J Rare Dis 2012 ; 7 : 91. [CrossRef] [PubMed] [Google Scholar]
  8. Wu X, Katz E, Della Valle MC, et al. A pharmacogenetic approach to identify mutant forms of alpha-galactosidase A that respond to a pharmacological chaperone for Fabry disease. Hum Mut 2011 ; 32 : 965–977. [CrossRef] [Google Scholar]
  9. Guce AI, Clark NE, Rogich JJ, Garman SC. The molecular basis of pharmacological chaperoning in human alpha-galactosidase. Chem Biol 2011 ; 18 : 1521–1526. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.